About David Gobel
Form D filings for Turn Biotechnologies in 2023 list David Gobel as director.
David Gobel first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name David Gobel in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Gobel works with at each company, as listed on that company's latest Form D.
Turn Biotechnologies, Inc. · Form D, Sep 6, 2023
VS
Vittorio Sebastiano
Director
MQ
Marco Quarta
Director
SC
Sergio Ruiz-Chinchilla
Executive officer
AK
Anja Krammer
Chief Executive Officer and director
RP
Ric Peterson
Executive officer